News & Articles
Selected Filters:
Advances in Sequencing Technology Facilitate Gene Expression Analyses at the Epigenomic Level
Three leading scientists discuss their research and the benefits of ChIP-Sequencing
Conferee Registration Opens for Pittcon 2017
New registration company offers advanced features
OGT Simplifies Detection of Important Cancer Gene Variants
SureSeq myPanel™ NGS Custom Cancer Panels enable researchers to create bespoke probe panels from an expert-curated library
Exclusive Liquid Biopsy Video Interviews
Hear from experts in the field on the revolutionary technique of liquid biopsies
Optimized and Automated Protocols for Cancer Diagnostics
Using liquid biopsies to detect cancer mutations
Exclusive Liquid Biopsy Editorial Articles and News
A round-up of the latest news and editorial articles on the hot topic of liquid biopsies
Horizon Discovery and Fulcrum Therapeutics Form Collaboration for Novel CRISPR-Based Target Discovery in Genetic Diseases
Exploration into the development of next-generation therapies
Singulex Granted ISO 13485:2012 Certification
Ensures Quality, Safety and Efficiency for Proprietary Technology
New Method to Assess Effectiveness of Genome-Editing Technologies
Droplet Digital™ PCR–based assay quickly and cost-effectively assesses genome-editing events
Breaking New Ground in Transcriptomics: Resolve Full-Length Transcripts for Unprecedented Insights into Novel Isoforms and Disease-Causing Splicing Variants
GATC Biotech’s INVIEW TRANSCRIPTOME ISOFORM DISCOVER establishes a new quality standard for all isoform-related research
Thermo Fisher Scientific Announces Next-Generation Sequencing Assay for Liquid Biopsy Research
Oncomine Cell-Free DNA Assay is designed to target and detect mutations down to 0.1 percent allele frequencies from whole blood derived from lung cancer tumors